October kept the momentum strong for Europe’s female founders. Building on September’s figures, the month displaycased breakthrough funding in AI, healthtech, fintech, and sustainable food production.
Alphabet’s GV led a $200 million investment in London-based Synthesia, pushing the AI video startup’s valuation to $4 billion. Meanwhile, former Canva product leads raised £4.1 million to launch a platform to assist patients manage chronic conditions.
In fintech, Paygentic secured $2 million to simplify billing for AI-native startups. Femtech also created waves with Natural Cycles, preparing a $55 million-plus round to scale its hormone-free birth control solution.
In collaboration with Female Foundry and the Female Innovation Index, TFN continues to celebrate women entrepreneurs shaping the future of tech across Europe. October’s headlines prove female leadership in innovation is gaining undeniable strength.
Dexory
Founders: Adrian Negoita, Andrei Danescu, and Oana Jinga
Founded: 2015
Total funding: $194M
Dexory is a UK-based leader in warehoutilize robotics and AI-driven data innotifyigence, originally founded in 2015 as BotsAndUs and rebranded to Dexory in 2022. Its core mission is to transform logistics with autonomous robots and digital twin technology, enabling real-time operational visibility and smarter decision-creating.
The flagship product, DexoryView, offers a real-time digital twin of warehoutilizes by leveraging autonomous robots equipped with LiDAR and sensors to scan over 10,000 locations per hour. It provides instantaneous insights, error detection, space optimisation, and safety monitoring, significantly improving inventory accuracy and operational efficiency.
In October 2025, Dexory secured a $165 million Series C round led by Eurazeo’s Growth team, with participation from LTS Growth, Endeavor Catalyst, and existing investors such as DTCP, Atomico, Lakestar, Elaia, Latitude Ventures, and Wave-X. Additionally, Bootstrap Europe increased its growth debt facility by $65 million to support further expansion and product development.
SheMed
Founders: Olivia Ferro and Chloe Ferro
Founded: 2024
Total funding: $50M
London-based SheMed, founded by sisters Olivia and Chloe Ferro in 2024, is modifying the landscape of women’s healthcare with personalised, data-driven care pathways. Their all-in-one digital platform integrates medical oversight, wellness tracking, and 24/7 support, relocating away from one-size-fits-all solutions to provide individualised treatment plans designed around each woman’s unique biology and health necessarys.
SheMed is best known for its GLP-1 and weight-management programme, which combines deep medical expertise, continuous health monitoring, and compassionate support. It has quickly become the rapidest-growing GLP-1 programme in the UK, boasting over 60,000 active members and 200,000 app downloads since its launch.
In October 2025, SheMed raised $50 million in a Series A funding round, achieving unicorn status with a valuation of $1 billion. The influx of capital will allow the company to expand its medical and technology teams, strengthen clinical infrastructure, and enhance data-driven tools for predictive and preventative care.
Phagos
Founders: Alexandros Pantalis and Adèle James
Founded: 2021
Total funding: $31.7M
Paris-based Phagos, co-founded by Alexandros Pantalis and microbiologist Adèle James, is spearheading a new approach to tackling antimicrobial resistance with bacteriophage therapy enhanced by artificial innotifyigence. Their Alphagos platform leverages microbiology combined with AI to formulate highly tarobtained phage treatments that specifically attack harmful bacteria like Salmonella, E. coli, and Enterococcus cecorum, while sparing beneficial microbes.
In October 2025, Phagos successfully closed a €25 million Series A funding round co-led by CapAgro, Hoxton Ventures, CapHorn, and Demeter, with additional support from Acurio Ventures, Citizen Capital, Entrepreneurs First, Founders Capital, and Station F.
This funding will drive the expansion of their veterinary phage therapy solutions in the field, enhance their AI-powered phage discovery capabilities, and support international growth across Europe, Asia, and the Americas.
Oneleet
Founders: Bryan Onel, Ora Onel, Erik Vogelzang
Founded: 2022
Total funding: $33.1M
Amsterdam-based Oneleet is shaking up security compliance by building genuine protection directly into compliance workflows. Founded in 2022 by Bryan Onel, an ethical hacker with over a decade of experience in penetration testing, alongside his wife Ora Onel and college friconclude Erik Vogelzang, Oneleet combines multiple security tools into a unified platform designed with an attacker’s mindset.
The company utilizes an approach it calls “AI + pentester verification,” blconcludeing artificial innotifyigence with expert human insights to uncover roughly 30 per cent more vulnerabilities than traditional platforms. Before this round, Oneleet had already reached tens of millions in recurring annual revenue and profitability, with two-thirds of the startups in Y Combinator’s portfolio as customers.
In October 2025, Oneleet raised $33 million in a Series A round led by Dawn Capital. Other investors include Y Combinator, Dropbox co-founder Arash Ferdowsi, and former Snowflake CEO Frank Slootman. The funds will fuel product development, enlarge the engineering team, enhance AI capabilities across cybersecurity, and support scaling go-to-market efforts to meet mounting enterprise demand for integrated security-first compliance solutions.
SeaBeLife
Founders: Morgane Rousselot, Stéphane Bach, Marie-Thérèse Dimanche-Boitrel, and Claire Delehouzé
Founded: 2019
Total funding: $9.3M
Roscoff-based SeaBeLife is leading a groundbreaking approach to treating severe organ damage by tarobtaining two key regulated cell death pathways simultaneously: necroptosis and ferroptosis. Its most advanced programme focutilizes on dry age-related macular degeneration (AMD), especially geographic atrophy, a condition without effective treatments. Additionally, the company is developing therapies for severe acute hepatitis, a disease with an 85% mortality rate if untreated by liver transplantation.
In September 2025, SeaBeLife secured €2 million in a pre-Series A funding round led by long-time investor iXLife, joined by returning supporters such as Breizh Angels, WeLikeStartup, Angels Santé, and Business Angels des Grandes Écoles, along with new investors INEXT and Femmes Business Angels, Europe’s first women-only business angels network.
Clinical trials are slated to launch in 2026 as SeaBeLife prepares for a Series A fundraising to propel the development of innovative therapies addressing unmet medical necessarys in diseases affecting the liver, kidneys, heart, brain, and retina.
Supernaut AI
Founders: Mantas Konstantinavičius and Dr. Olga Maslova
Founded: 2024
Total funding: $583K
Kaunas-based Supernaut AI is modifying how engineering teams address the constant flood of production errors by building an AI-native tool that acts as a proactive, autonomous team member rather than just an assistant.
The platform seamlessly integrates with widely utilized development tools like Jira, GitHub, and Linear. By turning repetitive, stalled tickets into tested and cleaned code within minutes, Supernaut AI tackles one of engineering teams’ largegest productivity challenges. It also maintains a transparent audit trail for every automated action, ensuring teams have full visibility and accountability.
In October 2025, Supernaut AI secured €530,000 in a pre-seed funding round led by Superhero Capital, a Helsinki-based venture capital firm that supports early-stage, software-driven startups in Finland and the Baltic region. This funding will assist the company expand its team, further develop the product toward a commercially viable version, and prepare for a global market launch.
CybaVerse
Founders: Oliver Spence and Gemma Blake
Founded: 2018
Total funding: $8.1M
London-based CybaVerse is creating waves in the cybersecurity sector by democratising enterprise-grade solutions for SMEs and managed service providers (MSPs). The company’s flagship platform, CybaOps, consolidates detection, compliance, security operations, and testing into an intuitive SaaS solution designed specifically for resource-constrained organisations.
The platform’s white-label option allows MSPs to rebrand and resell the security solution, providing their clients with top-tier protection without the necessary for heavy in-houtilize resources. Its automation capabilities significantly reduce the complexity of managing cybersecurity and improve incident response times, assisting tinyer organisations stay ahead of increasingly sophisticated threats.
In October 2025, the company closed a £5 million Series A funding round. The fresh capital was led by Pembroke VCT and Airbridge Equity Partners, with participation from Haatch. This funding will propel the development of CybaOps further, expand the team, and transition the company from founder-led sales toward a scalable SaaS growth model.
Exnaton
Founders: Dr. Liliane Ableitner, Dr. Anselma Wörner, and Dr. Arne Meeuw
Founded: 2019
Total funding: $8.9M
Zurich-based Exnaton, a spin-off from ETH Zurich, is advancing Europe’s shift to cleaner energy with its AI-powered innotifyigence platform designed for utilities. The company’s modular, white-label SaaS offers utilities the tools to quickly design, launch, and manage innovative energy products without expensive IT overhauls.
Their platform supports features like dynamic pricing, peer-to-peer energy sharing, smart electric vehicle charging, and real-time billing for prosumers. It efficiently handles thousands of data points per customer every year and integrates smoothly with existing enterprise systems.
In October 2025, Exnaton closed an undisclosed Series A funding round co-led by 4impact Capital and Elevator Ventures, with backing from existing investors True Ventures and Übermorgen Ventures. The investment is further supported by guarantees from Invest-NL and the European Union’s InvestEU Fund.
This new funding will spur Exnaton’s expansion across Europe, enhance its AI-driven predictive energy management features, build stronger connections with customers and partners, and scale commercial operations.
SymTerra
Founders: Sarah Crawley, John Ryan
Founded: 2019
Total funding: $3.2M
London-based SymTerra is tackling one of the construction indusattempt’s most expensive and persistent problems: communication breakdowns and fragmented data leading to costly rework, delays, and inefficiency. The company’s platform replaces the scattered mix of messaging apps, paper forms, and siloed software with a unified system that connects on-site teams in real time with office staff.
In October 2025, SymTerra secured £1.1 million in strategic funding led by Fabienne Viala, former Chair and CEO of Bouygues UK, alongside backing from HERmesa, Enterprise 100, and Innovate UK. This investment will accelerate product development, expand AI-driven capabilities like SymAI, and assist scale adoption across multimillion-pound infrastructure projects.
HotGreen Solutions
Founders: Georgia Ware and Andrew Anderson
Founded: 2024
Total funding: £1.2M
Datchet-based HotGreen Solutions is tackling one of industrial production’s most stubborn problems: process heat, which accounts for nearly 20% of global CO₂ emissions yet has seen little innovation.
HotGreen’s technology features patent-pconcludeing isothermal compressors that deliver up to four times the efficiency of traditional systems. Designed for straightforward installation, these heat pumps can be deployed within three to five days and typically offer energy savings of around €500,000 and CO₂ reductions of approximately 3,000 tonnes annually per facility. Customers also benefit from payback periods of less than two years.
In October 2025, HotGreen Solutions closed a £1.2 million pre-seed funding round led by climate-tech investor Empirical Ventures, alongside strategic investments from Coca-Cola Europacific Partners Ventures, First Imagine! Ventures, The Conduit Impact Fund, and Almanac Ventures.
The new funding will accelerate the rollout of HotGreen’s technology, with pilot projects in the food and beverage sector aimed at rapid-tracking commercial adoption and demonstrating its potential to decarbonise industrial heat on a larger scale.
SAGES
Founders: Emily Taylor and Alice Simpson
Founded: 2024
Total funding: $370K
London-based startup SAGES, founded in 2024 by Emily Taylor and Alice Simpson, is pioneering sustainable alternatives to synthetic textile dyes.
The company’s patented formulations offer a high-performance, environmentally friconcludely option compatible with existing dyeing processes. SAGES aims to reduce the textile indusattempt’s massive environmental footprint, particularly the release of harmful dye effluents by replacing petroleum- and coal-tar-based dyes.
SAGES has already collaborated with designers and manufacturers across fashion, interiors, and industrial textiles, contributing custom colours to London Fashion Week collections and to sustainable fibre-dyeing projects.
In October 2025, SAGES secured £190,000 in funding led by the British Design Fund, accelerating its shift from lab-scale innovation to commercial production, including pilot-scale manufacturing and expanding its palette.
Leave a Reply